Medicine Man Technologies (OTC: MDCL) On track for $40 million+ cannabis business

Medicine Man




Andy Williams







Medicine Man Technologies (OTC: MDCL) CEO Interview with Andy Williams on the company’s recent progress. Topics discussed, include:

– Record revenue and earnings growth for 2018: $9,442,555 revenues (+ 168% over 2017). Income  of $2,170,341 vs. net loss of $5,235,950 in 2017.

– Update on MedPharm Holdings, LLC and Medicine Man Denver acquisitions which are expected to result in $40 million + revenue run rate for the combined company.

– Impact of newly passed Colorado legislation which now allows public company ownership of Marijuana licenses (how this opens up M&A opportunities).

– Discussion of MedPharm Holdings LLC, early stage research & development of cannabinoid-based pharmaceuticals targeting dementia & Alzheimers.

– M&A growth strategy for Colorado and national

 – And more!


Medicine man presentation 4.10.19_FINAL


Did you enjoy this article? Join our FREE Newsletter!
I agree to have my personal information transfered to MailChimp ( more information )
Join over 100,000 investors and business leaders worldwide. Get the latest actionable business and investing intelligence before the rest of the crowd.
We hate spam. Your email address will not be sold or shared with anyone else.